AI Insight
A study examining the effectiveness of the FDA's 2021 voluntary sodium reduction targets found that the initiative had minimal impact on the sodium content of packaged food products. Researchers compared sodium levels in new products introduced before and after the FDA issued Phase I guidance, which set voluntary targets for manufacturers to reduce sodium by 2024. The analysis revealed no significant difference in sodium content between products launched before and after the guidance was issued.
Why it matters
This finding suggests that voluntary sodium reduction targets may be insufficient to meaningfully reduce sodium intake in the American diet, which has important implications for public health efforts to address hypertension and cardiovascular disease. The results may inform future policy decisions about whether mandatory limits or alternative regulatory approaches are needed to achieve meaningful sodium reduction in processed foods.
Understand the Science
In 2021, the U.S. Food and Drug Administration (FDA) issued Phase I voluntary sodium reduction targets to encourage manufacturers to lower the amount of sodium in packaged food products by 2024. The targets appear to have had minimal impact, according to a study comparing the sodium content of new products introduced before and after the guidance was issued.